Periosteal Electrical Dry Needling for Knee Osteoarthritis

NCT05365061 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 586

Last updated 2024-06-12

No results posted yet for this study

Summary

The purpose of this research is to treat patients with knee osteoarthritis (OA) with periosteal electric dry needling (PEDN). It is also to determine the optimal "maintenance" regiment (i.e. maintenance treatments, one maintenance treatment every other month, or one maintenance treatment per month) required to maintain improvements in pain and function following PEDN. Physical therapists commonly use PEDN to treat knee OA, and previous studies suggest that this treatment is useful for reducing pain and improving function in patients with osteoarthritis. However, an appropriate maintenance treatment strategy to maintain these outcomes is presently unknown.

Conditions

Interventions

OTHER

periosteal electrical dry needling with no maintenance treatments

periosteal electrical dry needling

OTHER

periosteal electrical dry needling with maintenance treatments every other month

periosteal electrical dry needling with maintenance treatments every other month

OTHER

periosteal electrical dry needling with monthly maintenance treatments

periosteal electrical dry needling with monthly maintenance treatments

Sponsors & Collaborators

  • Universidad Rey Juan Carlos

    collaborator OTHER
  • Alabama Physical Therapy & Acupuncture

    lead OTHER

Principal Investigators

  • James Dunning, PhD DPT · American Academy of Manipulative Therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05365061 on ClinicalTrials.gov